PlainRecalls
FDA Drug Moderate Class II Terminated

Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.

Reported: February 13, 2013 Initiated: January 30, 2013 #D-147-2013

Product Description

Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.

Reason for Recall

Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.

Details

Units Affected
1,894 bottles
Distribution
Nationwide
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 1,894 bottles.
Why was this product recalled?
Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 13, 2013. Severity: Moderate. Recall number: D-147-2013.